Sudhir Vrundavandas Valia
Director
Pharmaceuticals
Taro Pharmaceutical Industries Ltd
Canada
Biography
Mr. Sudhir Vrundavandas Valia is Chief Financial Officer & Director at Sun Pharma Advanced Research Co. Ltd. and a Member at Institute of Chartered Accountants of India. He is on the Board of Directors at Taro Pharmaceutical Industries Ltd., Alkaloida Chemical Co. Exclusive Group Ltd., Sun Pharma Advanced Research Co. Ltd., Caraco Pharmaceutical Laboratories Ltd., Sun Pharmaceuticals Corp., Sun Pharmaceutical Industries Ltd., Sun Petrochemicals Pvt Ltd., Nisha Capital Services Pvt Ltd., Universal Enterprises Ltd., Aditya Thermal Energy Pvt Ltd., Alfa Infraprop Pvt Ltd., Shantilal Shanghvi Foundation, Sun Pharma de Mèxico SA de CV, SPIL de Mexico SA de CV, Sun Pharmaceutical Industries, Inc., Morley & Co., Inc., Taro Development Corp., Taro Pharmaceuticals North America, Inc., Taro Pharmaceuticals USA, Inc., Aditya Acquisition Co. Ltd., Sejraj Financial Services Pvt Ltd., Karad Chemicals & Allied Products Pvt Ltd., Lakshadeep Investment & Finance Pvt Ltd., Minaxi Fiscal Services Pvt Ltd., Eklavya Securities Ltd., Suraksha Realty Ltd., Krishna Vrundavan Pratishthan, Sun Pharmaceutical Industries Europe BV, Sun Global Canada Pty Ltd., Taro Pharmaceuticals Canada Ltd., and Taro International Ltd. Mr. Sudhir Vrundavandas Valia is Chief Financial Officer & Director at Sun Pharma Advanced Research Co. Ltd. and a Member at Institute of Chartered Accountants of India. He is on the Board of Directors at Taro Pharmaceutical Industries Ltd., Alkaloida Chemical Co. Exclusive Group Ltd., Sun Pharma Advanced Research Co. Ltd., Caraco Pharmaceutical Laboratories Ltd., Sun Pharmaceuticals Corp., Sun Pharmaceutical Industries Ltd., Sun Petrochemicals Pvt Ltd., Nisha Capital Services Pvt Ltd., Universal Enterprises Ltd., Aditya Thermal Energy Pvt Ltd., Alfa Infraprop Pvt Ltd., Shantilal Shanghvi Foundation, Sun Pharma de Mèxico SA de CV, SPIL de Mexico SA de CV, Sun Pharmaceutical Industries, Inc., Morley & Co., Inc., Taro Development Corp., Taro Pharmaceuticals North America, Inc., Taro Pharmaceuticals USA, Inc., Aditya Acquisition Co. Ltd., Sejraj Financial Services Pvt Ltd., Karad Chemicals & Allied Products Pvt Ltd., Lakshadeep Investment & Finance Pvt Ltd., Minaxi Fiscal Services Pvt Ltd., Eklavya Securities Ltd., Suraksha Realty Ltd., Krishna Vrundavan Pratishthan, Sun Pharmaceutical Industries Europe BV, Sun Global Canada Pty Ltd., Taro Pharmaceuticals Canada Ltd., and Taro International Ltd.
Research Interest
Pharmaceuticals
